Brisbane cycle challenge launched to blow lung disease away
Lung Foundation Australia is calling on groups of friends and colleagues in Brisbane to help raise much needed funding for lung disease research by registering on their website now for the 2017 Corporate Cycle Challenge, which is proudly supported by Novartis.
Teams of 5 are encouraged to sign-up for the unique 4 hour cycle challenge, which will take place on Friday 14 July at Lakeside Park Raceway in Brisbane, and to raise as much funds as they can between now and the day of the challenge by encouraging friends, family and colleagues to sponsor their team.
Lung Foundation Australia CEO Ms Heather Allan said everyone who registers will be raising funds for research that will help improve the lives of the 1 in 4 Australians currently living with a lung disease.
“Lung disease, including thoracic cancers and chronic respiratory diseases, is the second leading cause of death in Australia1, yet publicity, empathy, research and funding remain extremely low,”Ms Allan said.
“For example, lung cancer, Australia’s biggest cancer killer, receives less than 5 cents of every tumour specific research dollar. This is compared to 26 cents for Breast Cancer and 13 cents for Prostate Cancer. Other chronic lung diseases, such as Chronic Obstructive Pulmonary Disease (COPD), have a similar research story to tell.
“Last year was the first time we held the Corporate Cycle Challenge and the Brisbane community rallied to raise an incredible $80,000. This year, we hope to reach $100,000.
“Thanks to the support of Novartis, we are able to commit 100% of the funds raised to support vital research into lung disease,” she said.
Brisbane mother of two, Anita McGrath, knows first-hand the vital role of lung disease research.
“In late 2013, doctors found a 4cm tumour on my right lung that is inoperable. Without funding from events like the Lung Foundation Corporate Cycle to support research, I may not have had the opportunity to be on the targeted therapy drug that has given me a relatively normal quality of life for the past two and a half years,” Mrs McGrath said.
“Research offers hope and undisputed benefits for improving outcomes for people with lung disease,” she said.
Novartis’ Business Franchise Director, Respiratory, Kate Norton, said they were pleased to be supporting this unique initiative.
“Novartis is committed to enhancing health outcomes for patients and health-care providers so we are delighted to be supporting Lung Foundation Australia to raise money for lung disease research,” Ms Norton said.
“We will be signing up a team and are encouraging everyone in Brisbane to get involved and support this worthy and important cause.”
Ms Heather Allan said you don’t have to be a cyclist to be involved, the event caters to all fitness levels.
“All you need is a working bicycle plus helmet and the passion to make a real difference in peoples’ lives,”Ms Allan said.
Register now via lungfoundation.com.au/cycle-challenge
1ABS, Australia’s Leading Causes of Death, 2015, www.abs.gov.au
Lung Foundation Australia is the only national charity dedicated to supporting anyone with a lung disease. For more information, visit lungfoundation.com.au